Leadership & Pay ·
Achieve Life Sciences, Inc. announced on October 1, 2026, that the Board appointed Benjamin Halladay as Chief…
ACHVAchieve Life Sciences, Inc.
Achieve Life Sciences, Inc. announced on October 1, 2026, that the Board appointed Benjamin Halladay as Chief Financial Officer and principal financial officer, effective October 5, 2026. Halladay brings prior experience as CFO of Esperion Therapeutics and holds a CPA designation. His employment agreement includes an annual base salary of $525,000, a discretionary bonus potential of up to 40%, and equity grants comprising 200,000 stock options and 200,000 restricted stock units with standard vesting schedules. Concurrently, Mark Oki stepped down as CFO effective October 5, 2026, with the separation attributed to no disagreement regarding financial statements or disclosures. Achieve Life Sciences operates in the biotechnology industry, focusing on drug discovery and development.